Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Schmeiser

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
European Journal of Internal Medicine|December 14, 2011
Arthritis in patients with systemic sclerosisTim Schmeiser, Jörn Pons-Kühnemann, Filiz Özden, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 29, 2006
Assessment of the DNA damaging potency and chemopreventive effects towards BaP-induced genotoxicity in human derived cells by Monimiastrum globosum, an endemic Mauritian plantVolker Mersch-Sundermann, Theeshan Bahorun, Thorsten Stahl, et al.
Arthritis and Rheumatism|September 2, 2008
Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosisMirko Manetti, Elena Neumann, Adelheid Müller, et al.
Clinical and Experimental Rheumatology|April 6, 2021
Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?Rebecca Hasseli, Alexander Pfeil, Bimba F Hoyer, et al.
Zeitschrift Fur Rheumatologie|July 1, 2021
[German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic]Rebecca Hasseli, Alexander Pfeil, Bimba Franziska Hoyer, et al.
RMD Open|September 4, 2020
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRDRebecca Hasseli, Ulf Mueller-Ladner, Tim Schmeiser, et al.
RMD Open|January 22, 2021
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseasesRebecca Hasseli, Ulf Mueller-Ladner, Bimba F Hoyer, et al.
RMD Open|October 21, 2021
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMDAnne Constanze Regierer, Rebecca Hasseli, Martin Schäfer, et al.
Annals of the Rheumatic Diseases|February 22, 2018
Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional studyMwidimi Ndosi, Begonya Alcacer-Pitarch, Yannick Allanore, et al.
Rheumatology (Oxford, England)|April 16, 2026
Treatment of systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease and its impact on survival: a large cohort study of the German network for systemic sclerosisMarc Schmalzing, Pia Moinzadeh, Jithmi Weliwitage, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Internal Medicine|December 14, 2011
Arthritis in patients with systemic sclerosisTim Schmeiser, Jörn Pons-Kühnemann, Filiz Özden, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 29, 2006
Assessment of the DNA damaging potency and chemopreventive effects towards BaP-induced genotoxicity in human derived cells by Monimiastrum globosum, an endemic Mauritian plantVolker Mersch-Sundermann, Theeshan Bahorun, Thorsten Stahl, et al.
Arthritis and Rheumatism|September 2, 2008
Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosisMirko Manetti, Elena Neumann, Adelheid Müller, et al.
Clinical and Experimental Rheumatology|April 6, 2021
Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?Rebecca Hasseli, Alexander Pfeil, Bimba F Hoyer, et al.
Zeitschrift Fur Rheumatologie|July 1, 2021
[German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic]Rebecca Hasseli, Alexander Pfeil, Bimba Franziska Hoyer, et al.
RMD Open|September 4, 2020
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRDRebecca Hasseli, Ulf Mueller-Ladner, Tim Schmeiser, et al.
RMD Open|January 22, 2021
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseasesRebecca Hasseli, Ulf Mueller-Ladner, Bimba F Hoyer, et al.
RMD Open|October 21, 2021
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMDAnne Constanze Regierer, Rebecca Hasseli, Martin Schäfer, et al.
Annals of the Rheumatic Diseases|February 22, 2018
Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional studyMwidimi Ndosi, Begonya Alcacer-Pitarch, Yannick Allanore, et al.
Rheumatology (Oxford, England)|April 16, 2026
Treatment of systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease and its impact on survival: a large cohort study of the German network for systemic sclerosisMarc Schmalzing, Pia Moinzadeh, Jithmi Weliwitage, et al.
Pageof 3